DG Peptide Protocols
Well StudiedLongevityMetabolic

MOTS-c

Mitochondrial Open Reading Frame of the 12S rRNA-c

Mitochondrial-Derived Peptide | Metabolic Regulator

Half-life
~30 minutes
Chain length
16 amino acids
Reference frequency
Daily for metabolic support, or 3x weekly for anti-aging

Research overview

DoseGear research brief

MOTS-c is a mitochondrial-derived peptide that operates as a mitohormone through the Folate-AICAR-AMPK pathway. Under metabolic stress, it translocates to the nucleus to bind stress-response transcription factors (NRF2, ATF1/ATF7), regulating genes involved in metabolism and cellular adaptation.

Mechanism of action

Inhibits the folate cycle leading to AMPK activation. Under metabolic stress, translocates to nucleus to bind stress-response transcription factors, regulating genes involved in metabolism, insulin sensitivity, and cellular adaptation.

Compound background

Development & research timeline

Study windows describe what researchers measured, not when an individual should expect a result.

Origin & development

Mitochondrial-DNA-associated peptide.

What it is researched for

Metabolic stress, insulin sensitivity, and aging research involving AMPK-associated signaling and stress-dependent nuclear actions.

Research observation window

Cell research observed nuclear translocation within 30 minutes under metabolic stress; this is not an injected-treatment response timeline.

Reference data

Lyophilized vial injectable protocols

Not personalized dosing instructions

Only injectable vial references are shown. Nasal, topical, and unsupported non-vial schedules are excluded.

Research contextAmountFrequencyRoute
Metabolic health5-10mgOnce dailySubQ
Anti-aging protocol15mg3x weeklySubQ
Exercise performance10-15mgPre-workoutSubQ
Conservative start5mgOnce dailySubQ

Reference cycle

4-12 weeks depending on goals

Reference storage

Refrigerate reconstituted solution at 2-8°C, use within 14 days

Safety context

Reported side effects

  • Generally well-tolerated in animal studies with minimal side effects
  • Mild injection site reactions (redness, swelling)

Contraindications & cautions

  • Pregnancy or breastfeeding
  • WADA prohibited substance (banned for athletic competition)
  • Limited long-term human safety data

Scientific references

  1. 01

    The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance

    Scientific citationThe Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance. Cell Metabolism (2015).
  2. 02

    The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress

    Scientific citationThe Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress. Cell Metabolism (2018).
  3. 03

    MOTS-c Is an Exercise-Induced Mitochondrial-Encoded Regulator of Age-Dependent Physical Decline and Muscle Homeostasis

    Scientific citationMOTS-c Is an Exercise-Induced Mitochondrial-Encoded Regulator of Age-Dependent Physical Decline and Muscle Homeostasis. Nature Communications (2021).
  4. 04

    MOTS-c Increases in Skeletal Muscle Following Long-Term Physical Activity and Improves Acute Exercise Performance After a Single Dose

    Scientific citationMOTS-c Increases in Skeletal Muscle Following Long-Term Physical Activity and Improves Acute Exercise Performance After a Single Dose. Physiological Reports (2022).

This DoseGear profile combines published scientific literature with lyophilized-vial protocol references. Citations are provided for independent review.

Related research profiles